Comparison of 18F-DOPA versus 68Ga-DOTA-TOC as preferred PET imaging tracer in well-differentiated neuroendocrine neoplasms

de Groot, D. J., Brouwers, A., Walenkamp, A. & Noordzij, W., Feb-2021, In: Journal of Neuroendocrinology. 33, p. 129-129 1 p.

Research output: Contribution to journal › Meeting Abstract › Academic

Comparison of F-18-DOPA Versus Ga-68-DOTATOC as Preferred PET Imaging Tracer in Well-Differentiated Neuroendocrine Neoplasms

Veenstra, E. B., de Groot, D. J. A., Brouwers, A. H., Walenkamp, A. M. E. & Noordzij, W., Mar-2021, In: Clinical Nuclear Medicine. 46, 3, p. 195-200 6 p.

Research output: Contribution to journal › Article › Academic › peer-review

Current Treatment Strategies and Future Directions for Extrapulmonary Neuroendocrine Carcinomas A Review: A Review

Stelwagen, J., de Vries, E. G. E. & Walenkamp, A. M. E., 25-Feb-2021, In: JAMA oncology. 12 p.

Research output: Contribution to journal › Review article › peer-review

Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma

Clement, P. M. J., Dirven, L., Eoli, M., Sepulveda-Sanchez, J. M., Walenkamp, A. M. E., Frenel, J. S., Franceschi, E., Weller, M., Chinot, O., De Vos, F. Y. F. L., Whenham, N., Sanghera, P., Looman, J., Kundu, M. G., Peter de Geus, J., Nuyens, S., Spruyt, M., Gorlia, T., Coens, C., Golfinopoulos, V. & 2 others, Reijneveld, J. C. & van den Bent, M. J., 15-Feb-2021, (E-pub ahead of print) In: European Journal of Cancer. 147, p. 1-12 12 p.

Research output: Contribution to journal › Article › Academic › peer-review

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

Martin, M., Mayer, I. A., Walenkamp, A. M. E., Lapa, C., Andreeff, M. & Bobirca, A., 22-Oct-2020, (E-pub ahead of print) In: Journal of Leukocyte Biology. p. 1-15 15 p.

Research output: Contribution to journal › Review article › peer-review